Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities VRDN - Viridian Therapeutics, Inc.
226 M
LAST VALUE
34.22%
2 YEAR CAGR
40.03%
5 YEAR CAGR
68.01%
10 YEAR CAGR